Introduction - Hormone-resistant prostate cancer

被引:0
|
作者
Coulange, C
Khoury, S
机构
来源
PROGRES EN UROLOGIE | 2002年 / 12卷 / 01期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5 / 5
页数:1
相关论文
共 50 条
  • [41] Comment to "Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel"
    Angulo, J. C.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (01): : 61 - 61
  • [42] Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells
    Yi, Xianlin
    Li, You
    Hu, XiaoGang
    Wang, FuBing
    Liu, Tiangang
    [J]. JOURNAL OF CANCER, 2021, 12 (10): : 2893 - 2902
  • [43] PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient
    Gasent Blesa, Joan M.
    Alberola Candel, Vicente
    [J]. ONKOLOGIE, 2010, 33 (1-2): : 57 - 59
  • [44] ESTRAMUSTINE PHOSPHATE IN SECONDARY HORMONE-RESISTANT CARCINOMA OF THE PROSTATE
    MAIER, U
    HIENERT, G
    SIMAK, R
    [J]. EUROPEAN UROLOGY, 1990, 17 (03) : 216 - 218
  • [45] FLUTAMIDE IN HORMONE-RESISTANT PROSTATIC-CANCER
    FOSSA, SD
    HOSBACH, G
    PAUS, E
    [J]. JOURNAL OF UROLOGY, 1990, 144 (06): : 1411 - 1414
  • [46] mTOR inhibition in hormone-resistant breast cancer
    Sharma, Sharan Prakash
    [J]. LANCET ONCOLOGY, 2012, 13 (06): : E239 - E239
  • [47] Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study
    EH Hernes
    SD Fosså
    S Vaage
    P Øgreid
    A Heilo
    E Paus
    [J]. British Journal of Cancer, 1997, 76 : 93 - 99
  • [48] Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: A phase II study
    Hernes, EH
    Fossa, SD
    Vaage, S
    Ogreid, P
    Heilo, A
    Paus, E
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (01) : 93 - 99
  • [49] Hormone-resistant prostate cancer: New therapies needed - The Ross/Kantoff article reviewed
    Berthold, Domintk R.
    Tannock, Ian F.
    [J]. ONCOLOGY-NEW YORK, 2007, 21 (02): : 194 - +
  • [50] Weekly docetaxel and 4-weekly zoledronic acid in hormone-resistant prostate cancer
    Bertelli, Gianfilippo
    Heouaine, Amid
    Arena, Giuseppe
    Botto, Ambrogio
    Garrone, Ornella
    Colantonio, Ida
    Occelli, Marcella
    Fea, Elena
    Giubergia, Silvia
    Merlano, Marco
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 113 - 113